CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
55 hedge funds and large institutions have $61.9M invested in Crescent Biopharma, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 8 closing their positions.
Holders
55
Holders Change
+1
Holders Change %
+1.85%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
19
Closed
8
Calls
$247K
Puts
$120K
Net Calls
+$127K
Net Calls Change
+$13K